Home ›
Trademark Categories ›
Pharmaceuticals ›
2012 ›
AR ›
ARPLEXAM
Trademark search for:
ARPLEXAM
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2012-03-27 — Application filed
2012-05-10 — Sn assigned for sect 66a appl from ib
2012-05-14 — Application filed
2012-05-18 — Application filed
2012-07-06 — Final disposition recorded
2012-07-06 — Assigned to examiner
2012-07-07 — Office action issued
2012-07-10 — Office action issued
2012-07-10 — Office action issued
2012-08-11 — Office action issued
2013-01-08 — Attorney/dom.rep.revoked and/or appointed
2013-01-08 — Office action issued
2013-01-08 — Teas revoke/app/change addr of atty/dom rep received
2013-01-10 — Assigned to lie
2013-01-17 — Teas/email correspondence entered
2013-01-17 — Correspondence received in law office
2013-02-08 — Assigned to examiner
2013-02-15 — Approved for pub - principal register
2013-02-21 — Law office publication review completed
2013-03-06 — Notification of possible opposition sent to ib
2013-03-06 — Notification of notice of publication e-mailed
2013-03-06 — Notice of start of opposition period created, to be sent to ib
2013-03-26 — Published for opposition
2013-03-26 — Official gazette publication confirmation e-mailed
2013-05-06 — Notification processed by ib
2013-06-11 — Registered-principal register
2013-09-11 — Final disposition recorded
2013-09-13 — Final disposition recorded
2013-09-13 — Final disposition recorded
2013-10-07 — Final disposition recorded
2018-06-11 — Courtesy reminder - sec. 71 (6-yr) e-mailed
2020-01-17 — Cancelled section 71
2020-09-17 — Total invalidation of reg ext protection created
2020-10-07 — Total invalidation of reg ext protection sent to ib
2020-10-07 — Invalidation processed
2020-11-01 — Total invalidation processed by the ib
2022-03-28 — Final status recorded
2022-10-16 — Death of international registration
2022-10-16 — Notification of effect of cancellation of intl reg e-mailed
Owner Information
BIOFARMA
FR
BIOFARMA
FR
BIOFARMA
FR
Correspondent
Rebecca B. Lederhouse Baker & McKenzie LLP Suite 5000 300 E. Randolph Street Chicago, IL 60601
Filing Details
Filing Date:
2012-03-27
Status Date:
2022-03-28
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.